2026 Oncology Market Access Trends

The oncology access landscape is increasingly shaped by a dynamic “tug of war” between payer-driven cost controls and provider-driven treatment decisions. This comprehensive report examines how expanding utilization management, evolving reimbursement models, and growing clinical optionality are reshaping access across oncology. It integrates payer and provider perspectives to outline the mechanisms of control emerging across the ecosystem and the external forces that may further shift the balance in the years ahead.